Skip to content

Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa

Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02002026
Enrollment
52
Registered
2013-12-05
Start date
2013-11-30
Completion date
2014-11-30
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placenta Previa Without Hemorrhage

Keywords

placenta previa, uterine artery ligation

Brief summary

This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.

Detailed description

This Study will address the effect of uterine artery ligation prior to fetal delivery during Cesarean section in cases with central placenta previa to guard against postpartum hemorrhage and to minimize blood loss.

Interventions

Uterine artery ligation during cesarean section before delivery of the baby

Sponsors

Minia Maternity University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of the internal os at ultrasound * Symptomatic Placenta previa with at least one episode of bleeding * Estimated gestational age within 28 to 40 weeks * Maternal age \> 18 years * Informed consent * Social affiliation

Exclusion criteria

* Premature rupture of membranes * Severe bleeding. * Abnormal fetal heart rates. * Pre-eclampsia, chorioamnionitis, severe chronic renal disease.

Design outcomes

Primary

MeasureTime frameDescription
Changes in hemoglobin levelhemoglobin level will be done baseline and will be repeated 24 hours after deliveryChanges in hemoglobin level before and after CS will reflect the amount of blood loss during operation

Secondary

MeasureTime frame
Degree of uterine contractility.During CS and within 3 hours after CS

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026